Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
Abstract Parkinson’s disease (PD) is characterised by the degeneration of A9 dopaminergic neurons and the pathological accumulation of alpha-synuclein. The p.A30P SNCA mutation generates the pathogenic form of the alpha-synuclein protein causing an autosomal-dominant form of PD. There are limited st...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa5d1e8ffb404e52b22f63112205442d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fa5d1e8ffb404e52b22f63112205442d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fa5d1e8ffb404e52b22f63112205442d2021-11-14T12:19:46ZGene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function10.1038/s41598-021-01505-x2045-2322https://doaj.org/article/fa5d1e8ffb404e52b22f63112205442d2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01505-xhttps://doaj.org/toc/2045-2322Abstract Parkinson’s disease (PD) is characterised by the degeneration of A9 dopaminergic neurons and the pathological accumulation of alpha-synuclein. The p.A30P SNCA mutation generates the pathogenic form of the alpha-synuclein protein causing an autosomal-dominant form of PD. There are limited studies assessing pathogenic SNCA mutations in patient-derived isogenic cell models. Here we provide a functional assessment of dopaminergic neurons derived from a patient harbouring the p.A30P SNCA mutation. Using two clonal gene-corrected isogenic cell lines we identified image-based phenotypes showing impaired neuritic processes. The pathological neurons displayed impaired neuronal activity, reduced mitochondrial respiration, an energy deficit, vulnerability to rotenone, and transcriptional alterations in lipid metabolism. Our data describes for the first time the mutation-only effect of the p.A30P SNCA mutation on neuronal function, supporting the use of isogenic cell lines in identifying image-based pathological phenotypes that can serve as an entry point for future disease-modifying compound screenings and drug discovery strategies.Peter A. BarbutiJochen OhnmachtBruno F. R. SantosPaul M. AntonyFrançois MassartGérald CrucianiClaire M. DordingLukas PavelkaNicolas CasadeiYong-Jun KwonRejko KrügerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Peter A. Barbuti Jochen Ohnmacht Bruno F. R. Santos Paul M. Antony François Massart Gérald Cruciani Claire M. Dording Lukas Pavelka Nicolas Casadei Yong-Jun Kwon Rejko Krüger Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function |
description |
Abstract Parkinson’s disease (PD) is characterised by the degeneration of A9 dopaminergic neurons and the pathological accumulation of alpha-synuclein. The p.A30P SNCA mutation generates the pathogenic form of the alpha-synuclein protein causing an autosomal-dominant form of PD. There are limited studies assessing pathogenic SNCA mutations in patient-derived isogenic cell models. Here we provide a functional assessment of dopaminergic neurons derived from a patient harbouring the p.A30P SNCA mutation. Using two clonal gene-corrected isogenic cell lines we identified image-based phenotypes showing impaired neuritic processes. The pathological neurons displayed impaired neuronal activity, reduced mitochondrial respiration, an energy deficit, vulnerability to rotenone, and transcriptional alterations in lipid metabolism. Our data describes for the first time the mutation-only effect of the p.A30P SNCA mutation on neuronal function, supporting the use of isogenic cell lines in identifying image-based pathological phenotypes that can serve as an entry point for future disease-modifying compound screenings and drug discovery strategies. |
format |
article |
author |
Peter A. Barbuti Jochen Ohnmacht Bruno F. R. Santos Paul M. Antony François Massart Gérald Cruciani Claire M. Dording Lukas Pavelka Nicolas Casadei Yong-Jun Kwon Rejko Krüger |
author_facet |
Peter A. Barbuti Jochen Ohnmacht Bruno F. R. Santos Paul M. Antony François Massart Gérald Cruciani Claire M. Dording Lukas Pavelka Nicolas Casadei Yong-Jun Kwon Rejko Krüger |
author_sort |
Peter A. Barbuti |
title |
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function |
title_short |
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function |
title_full |
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function |
title_fullStr |
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function |
title_full_unstemmed |
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function |
title_sort |
gene-corrected p.a30p snca patient-derived isogenic neurons rescue neuronal branching and function |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/fa5d1e8ffb404e52b22f63112205442d |
work_keys_str_mv |
AT peterabarbuti genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT jochenohnmacht genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT brunofrsantos genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT paulmantony genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT francoismassart genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT geraldcruciani genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT clairemdording genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT lukaspavelka genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT nicolascasadei genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT yongjunkwon genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction AT rejkokruger genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction |
_version_ |
1718429326447214592 |